Is there a generic for semaglutide in 2026? A Global and U.S. Overview
•
5 min read
While many Americans will not see a US Food and Drug Administration (FDA) approved generic semaglutide in 2026 due to patent protections, several major international markets are poised to introduce lower-cost versions of the popular drug in the same year. The global picture is highly segmented, contrasting countries where patents are expiring versus the United States where exclusivity extends well into the future.
